At LSC we specialise only in Life Sciences and always keep up to date with leading news, projects and all that’s going on in the industry. As the sector sees continued rapid growth it’s easy to miss some of the major announcements. To make things easier and to ensure you too are well informed we’ve selected and summarized this month’s top Irish Life Science news stories below.
Bausch + Lomb officially opens €85 million extension at the company’s Waterford facility adding 125 new jobs
Taoiseach Leo Varadkar TD and Tánaiste Frances Fitzgerald TD, Minister for Business, Enterprise and Innovation officially opened an €85 million extension at Bausch and Lomb’s Waterford facility as demand increases for their Biotrue® ONEday daily disposable contact lenses. The contact lens portfolio was developed by the R&D team in Waterford, and the site is the sole manufacturer of Biotrue® ONEday contact lenses globally. This investment will significantly strengthen the role the Waterford facility plays in increasing Bausch and Lomb’s market share in the contact lens market globally. This investment, supported by the Department of Enterprise through IDA Ireland, has created 125 additional jobs, bringing the total amount of people employed at the facility to 1,300. Read more >>
Synexa Life Sciences opens international headquarters in Dublin
Synexa Life Sciences, a specialist biomarker services provider has opened its international headquarters in Dublin. The new centre will be home to the company’s global business development activities and a new bioinformatics lab. 30 highly skilled jobs are to be created over the next five years at the Dublin headquarters. Commenting on the announcement, Martin Shanahan, CEO of IDA Ireland said, ‘The decision by Synexa, to locate its International Headquarters in Dublin, marks an important win for Ireland in further developing the pharmaceutical biotechnology sector. The Synexa headquarters will be a welcome addition to the ever expanding life sciences cluster in Ireland and I look forward to working with the company as it continues to grow”. Read more >>
GlaxoSmithKline to sell more than 130 brands in massive cost-saving drive
Global pharma company GSK plan to offload more than 130 of it’s non-core brands.
This is part of an extended cost reduction programme expected to deliver an additional £1 billion annual cost savings by 2020 under the newly appointed CEO Emma Walmsley. This follows a recent announcement from GSK to abandon plans for a new manufacturing plant in Cumbria, UK . “The Group has also undertaken a strategic review of its rare diseases unit and is now considering options for future ownership of these assets,” GSK said. GSK added that savings are earmarked for funding new product launches, research and development, and for offsetting price pressures. Read more >>
BioMarin 2 year expansion at Cork facility finally complete
Simon Coveney TD, Minister for Foreign Affairs and Trade, officially opened a new expansion at BioMarin Pharmaceutical Inc. in Shanbally, Cork driven by a rise in demand for medicine to treat rare diseases. The expansion at the Cork site will allow for continued growth and includes an expanded warehouse, new administration and utilities offices, a canteen and conference facilities. The overall project will allow BioMarin to maximise the flexibility of the site with the expansion of the operational manufacturing capacity. The site will also see the installation of a Waste Water Treatment Plant later this year, while three new lab expansions are to be completed by Q3 2018. Read more >>
Clean room development in Roscommon could create up to 300 pharma jobs
Announcements have been made that up to 300 jobs could be on the way for a new pharmaceutical facility in County Roscommon. The development could see seven different drug companies sharing a state-of-the-art ‘clean room. Roscommon TD and Communications Minister Denis Naughten said it is a unique prospect for any drug company looking to expand into the EU. Read more >>
Upskilling courses in the Life Sciences
12,000 potential job openings are to be created in the Irish Pharma, Biotech and Medical Device sectors by 2020. There are concerns that this rapid expansion will lead to a skills shortage in the industry. Initiatives are now in place to address these concerns and through the Springboard+ programme high quality upskilling courses are available to those looking to progress in the Life Sciences. Read more >>
2017 Europe Biotechnology Conference
Biologics will be the fastest growing sector of the pharmaceutical industry in the next decade. Nearly 30 to 40% of medical drugs will be made in the biopharmaceutical production process. Biologics are complex and require a high level of specialisation, which leads to the need for developing networks of big and small companies who can work together on similar projects. Management capabilities, such as project management and setting up supply and quality agreements, will also be needed now, more than ever before.
Join top pharmaceutical industry professionals and NIBRT, the National Institute for Bioresearch and Technology, as they address these questions and more at the ISPE 2017 Europe Biotechnology Conference in Dublin 26th – 27th September 2017. The Conference will highlight case studies and address the specific challenges and opportunities in managing technical projects related to the five megatrends in biotechnology. Read more >>